Is there any potential for first-line etravirine use? Analysis from a large data set of antiretroviral therapy-naive HIV-infected patients undergoing resistance test.
Zaccarelli
Mauro
M
Antinori
Andrea
A
Cozzi-Lepri
Alessandro
A
Mussini
Cristina
C
Palamara
Guido
G
Santoro
Maria Mercedes
MM
Spagnuolo
Vincenso
V
Monforte
Antonella d'Arminio
Ad
Perno
Carlo Federico
CF
Ceccherini-Silberstein
Francesca
F
D000293:Adolescent; D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D024882:Drug Resistance, Viral / Q000187:drug effects / Q000235:genetics / Q000502:physiology*; D005260:Female; D006678:HIV / Q000187:drug effects* / Q000235:genetics; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009154:Mutation / Q000187:drug effects / Q000235:genetics* / Q000502:physiology; D009570:Nitriles; D011724:Pyridazines / Q000627:therapeutic use*; D011743:Pyrimidines; D055815:Young Adult
D009570:Nitriles; D011724:Pyridazines; D011743:Pyrimidines; C451734:etravirine